Pharmaceutical Research and Manufacturers of America, formerly known as the Pharmaceutical Manufacturers Association, is a trade group representing companies in the pharmaceutical industry in the United States. Founded in 1958, PhRMA lobbies on behalf of pharmaceutical companies. PhRMA is headquartered in Washington, DC.
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. One of the world's largest independent biotechnology companies, Amgen's Thousand Oaks staff in 2022 numbered approximately 5,000 and included hundreds of scientists, making Amgen the largest employer in Ventura County. As of 2022, Amgen has approximately 24,000 staff in total.
Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd with production facilities in nine countries and affiliates or offices in five countries. Novo Nordisk is controlled by majority shareholder Novo Holdings A/S which holds approximately 28% of its shares and a majority (77%) of its voting shares.
The pharmaceutical industry in India was valued at an estimated US$42 billion in 2021 and is estimated to reach $130 billion by 2030. India is the world's largest provider of generic medicines by volume, with a 20% share of total global pharmaceutical exports. It is also the largest vaccine supplier in the world by volume, accounting for more than 60% of all vaccines manufactured in the world. Indian pharmaceutical products are exported to various regulated markets including the US, UK, European Union and Canada.
Servier Laboratories is an international pharmaceutical company governed by a non-profit foundation, with its headquarters in France (Suresnes).
The Association of the British Pharmaceutical Industry (ABPI) is the trade association for over 120 companies in the UK producing prescription medicines for humans, founded in 1891. It is the British equivalent of America's PhRMA; however, the member companies research, develop, manufacture and supply medicines prescribed for the National Health Service.
The Pharmaceutical Inspection Convention and Pharmaceutical Inspection Co-operation Scheme (PIC/S) are two international instruments between countries and pharmaceutical inspection authorities. The PIC/S is meant as an instrument to improve co-operation in the field of Good Manufacturing Practices between regulatory authorities and the pharmaceutical industry.
The Japan Pharmaceutical Manufacturers Association (JPMA) is the organization representing the research-based pharmaceutical industry operating in Japan.
Sun Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company headquartered in Mumbai, that manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients (APIs) in more than 100 countries across the globe. It is the largest pharmaceutical company in India and the fourth largest specialty generic pharmaceutical company in the world. The products cater to a vast range of therapeutic segments covering psychiatry, anti-infectives, neurology, cardiology, diabetology, gastroenterology, ophthalmology, nephrology, urology, dermatology, gynecology, respiratory, oncology, dental and nutritionals.
UHC2030, formerly known as the International Health Partnership (IHP+), is a global platform which brings together multiple stakeholders to take action to advance progress towards universal health coverage (UHC) by mobilizing political commitment, demanding and tracking accountability, and promoting collective action for health systems. The global platform is co-hosted by the World Health Organization, the World Bank and the OECD.
Claudio Cavazza was an Italian entrepreneur, Chairman and founder of the Sigma-Tau pharmaceutical company.
The pharmaceutical industry in Switzerland directly and indirectly employs about 135,000 people. It contributes 5.7% of the gross domestic product of Switzerland and 30% of the country's exports. In 2017 about 30% of Swiss exports were chemical products. In the same year Switzerland was the second largest exporter of packaged medicine in the world, with about 11% of the global total, worth $36.5 billion.
The Global Health Innovative Technology Fund, headquartered in Japan, is an international public-private partnership between the Government of Japan, 16 pharmaceutical and diagnostics companies, the Bill & Melinda Gates Foundation, the Wellcome Trust and United Nations Development Programme. It funds scientific research and development for anti-infectives and diagnostics for diseases that primarily affect the developing world. Bill Gates has noted that "GHIT draws on the immense innovation capacity of Japan’s pharmaceutical companies, universities and research institutions to accelerate the creation of new vaccines, drugs and diagnostic tools for global health." Margaret Chan, former Director-General of the World Health Organization, said: "The GHIT Fund has stepped in to provide that incentive in a pioneering model of partnership that brings Japanese innovation, investment and leadership to the global fight against infectious disease."
Olivier Brandicourt is a French business executive and physician, and the former chief executive officer of Sanofi.
Stefan Oschmann is a German businessman. He was the CEO of pharma group Merck.
The Verband Forschender Arzneimittelhersteller (vfa) or Association of Research-Based Pharmaceutical Companies, is the trade group of 43 pharmaceutical companies in Germany which are global players, representing more than two-thirds of the German pharmaceutical market, with nearly 80,000 employees in Germany.
The Swiss-Iranian Investment Forum (SIIF) is a Swiss nonprofit association, based in Geneva, Switzerland. Established as an international body, its mission is cited as "Global Initiative for responsible Investment” for promoting sustainable and responsible investment in Iran’s health, transportation, environmental, financial and other related and necessary sectors based on global finding about economic, social and environmental situation in Iran.
European Pharmaceutical Market Research Association (EPHMRA) is a European pharmaceutical market research association established in 1961. EPHMRA aimed to provide the best methods of market research and share it with the global community. It also aimed to improve the public’s general healthcare, by doing market research which then ensures the quality and safety of marketed pharmaceutical products. To ensure the research done is according to the ethical standard, EPHMRA developed the Code of Conduct and formulated the Ethics Committee.
Gisela Maame Abbam FRSA is a Ghanaian-British businesswoman working in both the private and public sector who has focused on the healthcare industry. She is the first black Chair of the General Pharmaceutical Council, and is the first black chair of the British Science Association. She is a board member of the Bar Standards Board, a commissioner on the National Preparedness Commission as well as a Senior director at Revvity. She is a former Global Executive Director at General Electric and an advisor at National Institute for Health and Care Excellence.
Matt Zeller is a pharmaceutical executive for Novartis and a former professional baseball player.
